Show simple item record

dc.creatorGluvić, Zoran
dc.creatorObradović, Milan M.
dc.creatorLačković, Milena
dc.creatorSamardžić, Vladimir S.
dc.creatorTica Jevtic, Jelena
dc.creatorEssack, Magbubah
dc.creatorBajić, Vladimir B.
dc.creatorIsenović, Esma R.
dc.date.accessioned2020-02-11T23:04:06Z
dc.date.available2020-02-11T23:04:06Z
dc.date.issued2019
dc.identifier.issn0269-4727
dc.identifier.urihttp://vinar.vin.bg.ac.rs/handle/123456789/8484
dc.description.abstractWhat is known and objective: The HbA1C marker used in assessing diabetes control quality is not sufficient in diabetes patients with thalassaemia. Case description: A male diabetic patient with thalassaemia was hospitalized due to distal neuropathic pain, right toe trophic ulcer, unacceptable five-point glycaemic profile and recommended HbA1C value. After simultaneously initiated insulin therapy and management of ulcer by hyperbaric oxygen, the patient showed improved glycaemic control and ulcer healing, which led to the patient's discharge. What is new and conclusion: In thalassaemia and haemoglobinopathies, due to discrepancies in the five-point glycaemic profile and HbA1C values, it is necessary to measure HbA1C with a different method or to determine HbA1C and fructosamine simultaneously. © 2019 The Authors. Journal of Clinical Pharmacy and Therapeutics Published by John Wiley & Sons Ltd.en
dc.language.isoen
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173033/RS//
dc.relationKAUST [4129]
dc.relationKAUST Base Research Fund [BAS/1/1606-01-01]
dc.relationKAUST Office of Sponsored Research (OSR) [FCC/1/1976-17-01]
dc.rightsrestrictedAccess
dc.rightsopenAccess
dc.sourceJournal of Clinical Pharmacy and Therapeutics
dc.subjectdiabetesen
dc.subjectfructosamineen
dc.subjectglycaemic controlen
dc.subjectglycaemic profileen
dc.subjectHbA1Cen
dc.subjectthalassaemiaen
dc.titleHbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature reviewen
dc.typearticleen
dc.rights.licenseARR
dc.rights.licenseBY-NC
dcterms.abstractБајиц, В Б; Обрадовиц, М; Исеновиц, Е Р; Глувиц, З; Лацковиц, М; Самардзиц, В; Тица Јевтиц, Ј; Ессацк, М;
dc.rights.holder© 2019 The Authors. Journal of Clinical Pharmacy and Therapeutics Published by John Wiley & Sons Ltd.
dc.citation.volume45
dc.citation.issue2
dc.citation.spage379
dc.citation.epage383
dc.identifier.wos000496728900001
dc.identifier.doi10.1111/jcpt.13073
dc.citation.rankM23
dc.identifier.pmid31736110
dc.type.versionpublishedVersion
dc.identifier.scopus2-s2.0-85075520848


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record